Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders
Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic ass...
Saved in:
Published in | Journal of neurodevelopmental disorders Vol. 15; no. 1; pp. 14 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
29.04.2023
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1866-1955 1866-1947 1866-1955 |
DOI | 10.1186/s11689-023-09483-z |
Cover
Abstract | Background
Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy.
Methods
Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (
n
= 7920), ASD (
n
= 4318), or both (
n
= 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case–control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity.
Results
Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein–protein interaction with mGluR 1–8 genes). Among CNVs in mGluR network genes, we uncovered
CNTN4
deletions enriched in NDD cases (
P
= 3.22E − 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (
P
= 5.26E − 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (
P
= 4.08E − 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (
P
= 9.21E − 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records.
Conclusion
Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in
CNTN4
, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD.
Trial registration
ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. |
---|---|
AbstractList | Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy. Methods Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case-control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity. Results Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein-protein interaction with mGluR 1-8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E - 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E - 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E - 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E - 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records. Conclusion Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD. Trial registration ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. Keywords: Neurodevelopmental disorders, Copy number variation, Genetic association study, Autism, Attention-deficit/hyperactivity disorder, Metabotropic glutamate receptors Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy.BACKGROUNDNeurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy.Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case-control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity.METHODSPlatforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case-control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity.Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein-protein interaction with mGluR 1-8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E - 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E - 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E - 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E - 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records.RESULTSHere, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein-protein interaction with mGluR 1-8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E - 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E - 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E - 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E - 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records.Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD.CONCLUSIONTogether, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD.ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016.TRIAL REGISTRATIONClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy. Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case-control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity. Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein-protein interaction with mGluR 1-8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E - 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E - 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E - 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E - 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records. Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD. ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. BackgroundNeurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy.MethodsPlatforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case–control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity.ResultsHere, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein–protein interaction with mGluR 1–8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E − 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E − 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E − 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E − 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records.ConclusionTogether, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD.Trial registrationClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. Abstract Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy. Methods Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case–control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity. Results Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein–protein interaction with mGluR 1–8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E − 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E − 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E − 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E − 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records. Conclusion Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD. Trial registration ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy. Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD (n = 7920), ASD (n = 4318), or both (n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case-control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity. Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein-protein interaction with mGluR 1-8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases (P = 3.22E - 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls (P = 5.26E - 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls (P = 4.08E - 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls (P = 9.21E - 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records. Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4, 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD. Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and partially overlapping phenotypes that often lack definitive corroborating genetic information. ADHD and ASD have complex genetic associations implicated by rare recurrent copy number variations (CNVs). Both of these NDDs have been shown to share similar biological etiologies as well as genetic pleiotropy. Methods Platforms aimed at investigating genetic-based associations, such as high-density microarray technologies, have been groundbreaking techniques in the field of complex diseases, aimed at elucidating the underlying disease biology. Previous studies have uncovered CNVs associated with genes within shared candidate genomic networks, including glutamate receptor genes, across multiple different NDDs. To examine shared biological pathways across two of the most common NDDs, we investigated CNVs across 15,689 individuals with ADHD ( n = 7920), ASD ( n = 4318), or both ( n = 3,416), as well as 19,993 controls. Cases and controls were matched by genotype array (i.e., Illumina array versions). Three case–control association studies each calculated and compared the observed vs. expected frequency of CNVs across individual genes, loci, pathways, and gene networks. Quality control measures of confidence in CNV-calling, prior to association analyses, included visual inspection of genotype and hybridization intensity. Results Here, we report results from CNV analysis in search for individual genes, loci, pathways, and gene networks. To extend our previous observations implicating a key role of the metabotropic glutamate receptor (mGluR) network in both ADHD and autism, we exhaustively queried patients with ASD and/or ADHD for CNVs associated with the 273 genomic regions of interest within the mGluR gene network (genes with one or two degrees protein–protein interaction with mGluR 1–8 genes). Among CNVs in mGluR network genes, we uncovered CNTN4 deletions enriched in NDD cases ( P = 3.22E − 26, OR = 2.49). Additionally, we uncovered PRLHR deletions in 40 ADHD cases and 12 controls ( P = 5.26E − 13, OR = 8.45) as well as clinically diagnostic relevant 22q11.2 duplications and 16p11.2 duplications in 23 ADHD + ASD cases and 9 controls ( P = 4.08E − 13, OR = 15.05) and 22q11.2 duplications in 34 ADHD + ASD cases and 51 controls ( P = 9.21E − 9, OR = 3.93); those control samples were not with previous 22qDS diagnosis in their EHR records. Conclusion Together, these results suggest that disruption in neuronal cell-adhesion pathways confers significant risk to NDDs and showcase that rare recurrent CNVs in CNTN4 , 22q11.2, and 16p11.2 are overrepresented in NDDs that constitute patients predominantly suffering from ADHD and ASD. Trial registration ClinicalTrials.gov Identifier: NCT02286817 First Posted: 10 November 14, ClinicalTrials.gov Identifier: NCT02777931 first posted: 19 May 2016, ClinicalTrials.gov Identifier: NCT03006367 first posted: 30 December 2016, ClinicalTrials.gov Identifier: NCT02895906 first posted: 12 September 2016. |
ArticleNumber | 14 |
Audience | Academic |
Author | Mentch, Frank Khan, Munir E. Slaby, Isabella March, Michael E. Hain, Heather Sleiman, Patrick M. A. Chang, Xiao Connolly, John Kao, Charlly Lemma, Maria Hakonarson, Hakon Otieno, F. George Glessner, Joseph T. Li, Jin Liu, Yichuan |
Author_xml | – sequence: 1 givenname: Joseph T. orcidid: 0000-0001-5131-2811 surname: Glessner fullname: Glessner, Joseph T. organization: Center for Applied Genomics, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania – sequence: 2 givenname: Munir E. surname: Khan fullname: Khan, Munir E. organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 3 givenname: Xiao surname: Chang fullname: Chang, Xiao organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 4 givenname: Yichuan surname: Liu fullname: Liu, Yichuan organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 5 givenname: F. George surname: Otieno fullname: Otieno, F. George organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 6 givenname: Maria surname: Lemma fullname: Lemma, Maria organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 7 givenname: Isabella surname: Slaby fullname: Slaby, Isabella organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 8 givenname: Heather surname: Hain fullname: Hain, Heather organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 9 givenname: Frank surname: Mentch fullname: Mentch, Frank organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 10 givenname: Jin surname: Li fullname: Li, Jin organization: Department of Cell Biology, the Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, School of Basic Medical Sciences, Tianjin Medical University – sequence: 11 givenname: Charlly surname: Kao fullname: Kao, Charlly organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 12 givenname: Patrick M. A. surname: Sleiman fullname: Sleiman, Patrick M. A. organization: Center for Applied Genomics, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania – sequence: 13 givenname: Michael E. surname: March fullname: March, Michael E. organization: Center for Applied Genomics, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania – sequence: 14 givenname: John surname: Connolly fullname: Connolly, John organization: Center for Applied Genomics, Children’s Hospital of Philadelphia – sequence: 15 givenname: Hakon surname: Hakonarson fullname: Hakonarson, Hakon email: hakonarson@chop.edu organization: Center for Applied Genomics, Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37120522$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks1q3DAUhU1JaX7aF-iiGAqlG6eSLdnWqoTQn0CgUNq1uJavPQq2NJXklOQJ-ti9mUmaTCjBCxnpO8e-R-cw23PeYZa95uyY87b-EDmvW1WwsiqYEm1VXD_LDuigLriScu_B-352GOMFY3VVSvki268aXjJZlgfZn-8QMA9olhDQpdz49VXulrnDkF9CsJCsdzG3Lp8xQedT8Gtr8nFaEsyQNlJcJx8ISRjAJOvGfESHG5FZ2akn4_y3Tavc4RJ8j5c4-fVMX4Mp7230occQX2bPB5givrpdj7Kfnz_9OP1anH_7cnZ6cl6YulKp4FXPa1MqbETHyl4gp5GGqm4BZNl2RgFjEqXpRFM3Vd2pGjoleuCyQahkVx1lZ1vf3sOFXgc7Q7jSHqzebPgwagjJmgl1R9GxWpSDEiBUy9TQokBRd_0gBwk9eX3ceq2Xbsbe0EgBph3T3RNnV3r0l5ozLlohFDm8v3UI_teCMenZRoPTBA79EnXZskbxRkpO6NtH6IVfgqOsiOKylow17T01Ak1g3UA3BubGVJ80opEUS9sQdfwfip4eZ2uoZYOl_R3BuweCFcKUVtFTCW7asQu-eRjJvyzuGkdAuwVM8DEGHLSxadMy-gU7UTT6ptx6W25N5dabcutrkpaPpHfuT4qqrSgS7EYM97E9ofoLZG4Oog |
CitedBy_id | crossref_primary_10_1159_000534123 crossref_primary_10_1186_s11689_024_09526_z crossref_primary_10_1016_j_pnpbp_2024_111107 crossref_primary_10_1021_acsomega_4c05522 crossref_primary_10_1016_j_neuropharm_2024_109897 |
Cites_doi | 10.1126/science.1138659 10.1038/nature07953 10.1101/gr.248682.119 10.1016/j.biopsych.2020.12.028 10.1093/nar/gks1346 10.1038/s41398-021-01763-3 10.1038/s41467-019-13624-1 10.1001/jamapsychiatry.2014.2650 10.1001/archpsyc.61.7.649 10.1007/7854_2011_179 10.1097/DBP.0000000000000065 10.1038/nrg3871 10.1016/j.gep.2020.119097 10.1038/ejhg.2015.269 10.1038/tp.2016.273 10.1038/ng.1013 10.1002/ajmg.b.30869 10.1016/j.pharmthera.2018.05.007 10.1016/j.brainres.2006.09.011 10.1038/s41398-019-0599-y 10.1016/j.neubiorev.2012.11.013 10.3389/fphar.2012.00159 10.1038/srep19372 10.1186/1755-8166-6-11 10.1016/j.celrep.2018.08.022 10.1016/j.jad.2015.10.004 10.3390/jcm10071475 10.1038/s41398-021-01223-y 10.1002/gepi.20303 10.1093/bib/bbaa381 10.1038/s41467-017-02244-2 10.1093/bioinformatics/btw477 10.1016/j.neuron.2010.01.016 10.1002/ajmg.b.32253 10.1016/j.neuropharm.2017.04.037 10.1038/sj.npp.1301312 10.1038/ng.474 10.1038/s41586-020-2287-8 10.1016/j.ijcard.2019.07.058 10.1007/s13760-021-01605-5 10.1101/gr.5402306 10.1503/jpn.130242 10.1038/sj.mp.4001940 10.1034/j.1399-5618.2003.00024.x 10.1186/s11689-022-09447-9 10.1101/gr.6861907 10.3389/fpsyt.2018.00767 10.1038/s41431-022-01222-7 10.1093/hmg/ddv436 10.1038/ncomms5074 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TK 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH K9. KB0 M0S M1P NAPCQ P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS PSYQQ RC3 7X8 5PM DOA |
DOI | 10.1186/s11689-023-09483-z |
DatabaseName | SpringerOpen Free (Free internet resource, activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1866-1955 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_b1950642f94a49809f8e4e46bdf5f5ad PMC10148449 A747547687 37120522 10_1186_s11689_023_09483_z |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Eunice Kennedy Shriver National Institute of Child Health and Human Development grantid: U54-HD086984 funderid: http://dx.doi.org/10.13039/100009633 – fundername: National Human Genome Research Institute grantid: 5U01HG011175-03; U01-HG006830 funderid: http://dx.doi.org/10.13039/100000051 – fundername: NICHD NIH HHS grantid: U54 HD086984 – fundername: NHGRI NIH HHS grantid: U01-HG006830 – fundername: NHGRI NIH HHS grantid: U01 HG011175 – fundername: NICHD NIH HHS grantid: P50 HD105354 – fundername: ; grantid: 5U01HG011175-03; U01-HG006830 – fundername: ; grantid: U54-HD086984 |
GroupedDBID | 0R~ 29L 2JY 4.4 53G 5GY 5VS 67Z 6NX 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABIVO ABUWG ACGFS ACPRK ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BA0 BAPOH BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CAG CCPQU CSCUP DU5 EBLON EBS EMOBN F5P FEDTE FYUFA GROUPED_DOAJ GXS HMCUK HVGLF HYE IAO IHR IHW INH INR IPY ITC IXC I~X KOV KQ8 M1P M48 NAPCQ O9I OK1 P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PSYQQ PUEGO QOS RBZ RNS ROL RPM RSV S27 SDH SMD SOJ T13 U2A UKHRP VC2 WK8 AAYXX ALIPV CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF HG6 M~E NPM PMFND 7TK 7XB 8FD 8FK AZQEC DWQXO FR3 K9. P64 PKEHL PQEST PQUKI PRINS RC3 7X8 5PM |
ID | FETCH-LOGICAL-c639t-13d16c29e74b02d4e1325f368aa528bc9a005e5cb476736b96ab94da157ea35b3 |
IEDL.DBID | M48 |
ISSN | 1866-1955 1866-1947 |
IngestDate | Wed Aug 27 01:19:50 EDT 2025 Thu Aug 21 18:38:01 EDT 2025 Fri Sep 05 04:58:22 EDT 2025 Fri Jul 25 05:11:57 EDT 2025 Tue Jun 17 21:38:12 EDT 2025 Tue Jun 10 20:45:20 EDT 2025 Thu May 22 21:18:48 EDT 2025 Thu Jan 02 22:40:30 EST 2025 Tue Jul 01 02:30:42 EDT 2025 Thu Apr 24 22:53:16 EDT 2025 Sat Sep 06 07:21:25 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Genetic association study Autism Metabotropic glutamate receptors Copy number variation Neurodevelopmental disorders Attention-deficit/hyperactivity disorder |
Language | English |
License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c639t-13d16c29e74b02d4e1325f368aa528bc9a005e5cb476736b96ab94da157ea35b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5131-2811 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s11689-023-09483-z |
PMID | 37120522 |
PQID | 2815650078 |
PQPubID | 2040182 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b1950642f94a49809f8e4e46bdf5f5ad pubmedcentral_primary_oai_pubmedcentral_nih_gov_10148449 proquest_miscellaneous_2807917551 proquest_journals_2815650078 gale_infotracmisc_A747547687 gale_infotracacademiconefile_A747547687 gale_healthsolutions_A747547687 pubmed_primary_37120522 crossref_citationtrail_10_1186_s11689_023_09483_z crossref_primary_10_1186_s11689_023_09483_z springer_journals_10_1186_s11689_023_09483_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-04-29 |
PublicationDateYYYYMMDD | 2023-04-29 |
PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Journal of neurodevelopmental disorders |
PublicationTitleAbbrev | J Neurodevelop Disord |
PublicationTitleAlternate | J Neurodev Disord |
PublicationYear | 2023 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | J Elia (9483_CR10) 2011; 44 9483_CR26 C RegioBrambilla (9483_CR43) 2022; 12 JT Glessner (9483_CR20) 2009; 459 TL Wenger (9483_CR12) 2016; 6 K Wang (9483_CR2) 2007; 17 J Wang (9483_CR28) 2020; 35 W Demaerel (9483_CR8) 2019; 29 9483_CR21 CT Li (9483_CR34) 2018; 9 J Lasky-Su (9483_CR27) 2008; 147B J Elia (9483_CR42) 2018; 9 SR Sharma (9483_CR32) 2018; 190 RL Collins (9483_CR4) 2020; 581 OO Gudmundsson (9483_CR18) 2019; 9 J Sebat (9483_CR22) 2007; 316 B Sun (9483_CR25) 2022; 122 I Slaby (9483_CR16) 2022; 14 YR Li (9483_CR6) 2020; 11 CF Bruinsma (9483_CR46) 2016; 25 C Bellone (9483_CR47) 2012; 3 J Naaijen (9483_CR15) 2017; 7 D Hadley (9483_CR13) 2014; 5 Q Qi (9483_CR30) 2013; 6 JT Glessner (9483_CR3) 2013; 41 RH Bitsko (9483_CR39) 2014; 35 M Mereu (9483_CR23) 2017; 121 C Luscher (9483_CR48) 2010; 65 TU Woo (9483_CR37) 2004; 61 CE McOmish (9483_CR44) 2016; 190 N Matosin (9483_CR45) 2014; 39 I Kushima (9483_CR29) 2018; 24 A Oguro-Ando (9483_CR19) 2021; 11 W Kryszkowski (9483_CR33) 2021; 10 JT Glessner (9483_CR11) 2012; 12 JT Glessner (9483_CR49) 2021; 22 E Scarr (9483_CR38) 2003; 5 ME Hirschtritt (9483_CR41) 2015; 72 I Pe'er (9483_CR51) 2008; 32 RE McCullumsmith (9483_CR35) 2007; 1127 JT Glessner (9483_CR7) 2020; 298 SE McCarthy (9483_CR17) 2009; 41 K Cheslack-Postava (9483_CR24) 2007; 12 DA Peiffer (9483_CR1) 2006; 16 M Beneyto (9483_CR36) 2007; 32 SC Cohen (9483_CR40) 2013; 37 J Fadista (9483_CR50) 2016; 24 GC Akutagava-Martins (9483_CR14) 2014; 165B A Mace (9483_CR5) 2016; 32 Z Yang (9483_CR31) 2021; 90 M Zarrei (9483_CR9) 2015; 16 |
References_xml | – volume: 316 start-page: 445 issue: 5823 year: 2007 ident: 9483_CR22 publication-title: Science doi: 10.1126/science.1138659 – volume: 459 start-page: 569 issue: 7246 year: 2009 ident: 9483_CR20 publication-title: Nature doi: 10.1038/nature07953 – volume: 29 start-page: 1389 issue: 9 year: 2019 ident: 9483_CR8 publication-title: Genome Res doi: 10.1101/gr.248682.119 – volume: 90 start-page: 317 issue: 5 year: 2021 ident: 9483_CR31 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2020.12.028 – volume: 41 issue: 5 year: 2013 ident: 9483_CR3 publication-title: Nucleic Acids Res doi: 10.1093/nar/gks1346 – volume: 12 start-page: 6 issue: 1 year: 2022 ident: 9483_CR43 publication-title: Transl Psychiatry doi: 10.1038/s41398-021-01763-3 – volume: 11 start-page: 255 issue: 1 year: 2020 ident: 9483_CR6 publication-title: Nat Commun doi: 10.1038/s41467-019-13624-1 – volume: 72 start-page: 325 issue: 4 year: 2015 ident: 9483_CR41 publication-title: JAMA Psychiat doi: 10.1001/jamapsychiatry.2014.2650 – volume: 61 start-page: 649 issue: 7 year: 2004 ident: 9483_CR37 publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.61.7.649 – volume: 12 start-page: 345 year: 2012 ident: 9483_CR11 publication-title: Curr Top Behav Neurosci doi: 10.1007/7854_2011_179 – volume: 35 start-page: 317 issue: 5 year: 2014 ident: 9483_CR39 publication-title: J Dev Behav Pediatr doi: 10.1097/DBP.0000000000000065 – volume: 16 start-page: 172 issue: 3 year: 2015 ident: 9483_CR9 publication-title: Nat Rev Genet doi: 10.1038/nrg3871 – volume: 35 year: 2020 ident: 9483_CR28 publication-title: Gene Expr Patterns doi: 10.1016/j.gep.2020.119097 – volume: 24 start-page: 1202 issue: 8 year: 2016 ident: 9483_CR50 publication-title: Eur J Hum Genet doi: 10.1038/ejhg.2015.269 – volume: 7 start-page: e999 issue: 1 year: 2017 ident: 9483_CR15 publication-title: Transl Psychiatry doi: 10.1038/tp.2016.273 – volume: 44 start-page: 78 issue: 1 year: 2011 ident: 9483_CR10 publication-title: Nat Genet doi: 10.1038/ng.1013 – volume: 147B start-page: 1355 issue: 8 year: 2008 ident: 9483_CR27 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.30869 – volume: 190 start-page: 91 year: 2018 ident: 9483_CR32 publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2018.05.007 – volume: 1127 start-page: 108 issue: 1 year: 2007 ident: 9483_CR35 publication-title: Brain Res doi: 10.1016/j.brainres.2006.09.011 – volume: 9 start-page: 258 issue: 1 year: 2019 ident: 9483_CR18 publication-title: Transl Psychiatry doi: 10.1038/s41398-019-0599-y – volume: 37 start-page: 997 issue: 6 year: 2013 ident: 9483_CR40 publication-title: Neurosci Biobehav Rev doi: 10.1016/j.neubiorev.2012.11.013 – volume: 3 start-page: 159 year: 2012 ident: 9483_CR47 publication-title: Front Pharmacol doi: 10.3389/fphar.2012.00159 – volume: 6 start-page: 19372 year: 2016 ident: 9483_CR12 publication-title: Sci Rep doi: 10.1038/srep19372 – volume: 6 start-page: 11 issue: 1 year: 2013 ident: 9483_CR30 publication-title: Mol Cytogenet doi: 10.1186/1755-8166-6-11 – volume: 24 start-page: 2838 issue: 11 year: 2018 ident: 9483_CR29 publication-title: Cell Rep doi: 10.1016/j.celrep.2018.08.022 – volume: 190 start-page: 241 year: 2016 ident: 9483_CR44 publication-title: J Affect Disord doi: 10.1016/j.jad.2015.10.004 – volume: 10 start-page: 1475 issue: 7 year: 2021 ident: 9483_CR33 publication-title: J Clin Med doi: 10.3390/jcm10071475 – volume: 11 start-page: 106 issue: 1 year: 2021 ident: 9483_CR19 publication-title: Transl Psychiatry doi: 10.1038/s41398-021-01223-y – volume: 32 start-page: 381 issue: 4 year: 2008 ident: 9483_CR51 publication-title: Genet Epidemiol doi: 10.1002/gepi.20303 – volume: 22 start-page: 381 issue: 5 year: 2021 ident: 9483_CR49 publication-title: Brief Bioinform doi: 10.1093/bib/bbaa381 – volume: 9 start-page: 4 issue: 1 year: 2018 ident: 9483_CR42 publication-title: Nat Commun doi: 10.1038/s41467-017-02244-2 – volume: 32 start-page: 3298 issue: 21 year: 2016 ident: 9483_CR5 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw477 – volume: 65 start-page: 445 issue: 4 year: 2010 ident: 9483_CR48 publication-title: Neuron doi: 10.1016/j.neuron.2010.01.016 – volume: 165B start-page: 502 issue: 6 year: 2014 ident: 9483_CR14 publication-title: Am J Med Genet B Neuropsychiatr Genet doi: 10.1002/ajmg.b.32253 – volume: 121 start-page: 179 year: 2017 ident: 9483_CR23 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2017.04.037 – volume: 32 start-page: 1888 issue: 9 year: 2007 ident: 9483_CR36 publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1301312 – volume: 41 start-page: 1223 issue: 11 year: 2009 ident: 9483_CR17 publication-title: Nat Genet doi: 10.1038/ng.474 – volume: 581 start-page: 444 issue: 7809 year: 2020 ident: 9483_CR4 publication-title: Nature doi: 10.1038/s41586-020-2287-8 – volume: 298 start-page: 107 year: 2020 ident: 9483_CR7 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2019.07.058 – volume: 122 start-page: 1169 issue: 5 year: 2022 ident: 9483_CR25 publication-title: Acta Neurol Belg doi: 10.1007/s13760-021-01605-5 – volume: 16 start-page: 1136 issue: 9 year: 2006 ident: 9483_CR1 publication-title: Genome Res doi: 10.1101/gr.5402306 – volume: 39 start-page: 407 issue: 6 year: 2014 ident: 9483_CR45 publication-title: J Psychiatry Neurosci doi: 10.1503/jpn.130242 – volume: 12 start-page: 283 issue: 3 year: 2007 ident: 9483_CR24 publication-title: Mol Psychiatry doi: 10.1038/sj.mp.4001940 – volume: 5 start-page: 257 issue: 4 year: 2003 ident: 9483_CR38 publication-title: Bipolar Disord doi: 10.1034/j.1399-5618.2003.00024.x – volume: 14 start-page: 37 issue: 1 year: 2022 ident: 9483_CR16 publication-title: J Neurodev Disord doi: 10.1186/s11689-022-09447-9 – volume: 17 start-page: 1665 issue: 11 year: 2007 ident: 9483_CR2 publication-title: Genome Res doi: 10.1101/gr.6861907 – ident: 9483_CR26 – volume: 9 start-page: 767 year: 2018 ident: 9483_CR34 publication-title: Front Psychiatry doi: 10.3389/fpsyt.2018.00767 – ident: 9483_CR21 doi: 10.1038/s41431-022-01222-7 – volume: 25 start-page: 1 issue: 1 year: 2016 ident: 9483_CR46 publication-title: Hum Mol Genet doi: 10.1093/hmg/ddv436 – volume: 5 start-page: 4074 year: 2014 ident: 9483_CR13 publication-title: Nat Commun doi: 10.1038/ncomms5074 |
SSID | ssj0063255 |
Score | 2.3316474 |
Snippet | Background
Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of... Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of complex and... Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of... BackgroundNeurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are examples of... Abstract Background Neurodevelopmental disorders (NDDs), such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), are... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 14 |
SubjectTerms | Adrenergic receptors Analysis Attention deficit hyperactivity disorder Autism Autism Spectrum Disorder - genetics Biology Biomedical and Life Sciences Biomedicine Cell adhesion & migration Copy number Copy number variation Disease DNA Copy Number Variations - genetics DNA microarrays Gene loci Genes Genetic aspects Genetic association study Genetic Predisposition to Disease Genetic research Genome-Wide Association Study Genomics Genotypes Glutamate Glutamic acid receptors (metabotropic) Human Genetics Humans Hybridization IDDRC 2023 Ligands Medical research Medicine, Experimental Metabotropic glutamate receptors Neurodevelopmental disorders Neurology Neuropsychology Neurosciences Pathophysiology Pediatrics Phenotypes Pleiotropy Protein-protein interactions Proteins Psychiatry Quality control Receptors, Metabotropic Glutamate - genetics |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2ggJGQOEDUJH7EPhZEVSGVA6JSb5ZfWVai2dXuFqn9Bf3ZzNjJtikCLlzjseTMjMcz9sw3hLzh3joVIy91YKzkzstSR4dP7Ir5mgdQASxOPvoiD4_55xNxcq3VF-aEZXjgzLg9h31KwUnuNLdcq0p3KvLIpQud6IQNaH0rXY3BVLbBkoGnPJbIKLm3rmuJqUENKyGcUay8mBxDCa3_d5t87VC6mTB549U0HUYH98jdwYuk-3n198mt2D8gt4-Gd_KH5PKrXUW6wrt0RF-ifrE8p7n5B_0J0XG-pqPznp7GDajBZrVYzj2dgRpacGHT1LiEcJwinEQqpOpndIZ2ESeNFeAUb3FpgsQMV8lHsLAwYHquH5Hjg0_fPh6WQ8-F0oOvgp3pQy19o2PLXdUEHiFaFR2TylrRKOe1hW0bhXe8xYwwp6V1mgdbizZaJhx7THb6RR-fEtpVcPI1PHgXFASdSlmlve20Ag9NxkoWpB5FYPwASI59MX6YFJgoabLYDIjNJLGZi4K8285ZZjiOv1J_QMluKRFKO30ABTODgpl_KVhBXqFemFyXujUIZh8CMQFcUG1B3iYKNAnwA94OlQ3ABgTXmlDuTihhK_vp8Kh7ZjAla9Mgno9AV64gr7fDOBPT4_q4OEOaqoW4G7zfgjzJqrr9adbWTQVedkHURIknXJmO9PPvCWgc-ziD6HRB3o_6frWuP7P92f9g-3Nyp0n7lZeN3iU7m9VZfAH-38a9TFv9F66lWS4 priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCNQLgvJooICRkDhA1Dwcxz6hgqgqpHJAVNqb5VeWlSBZdrdI7S_gZzPjOFlSRK_xWIo9D8_YM98Q8opZbYT3LJWuLFNmLE-lN_jELkqbMwcigMXJp5_5yRn7NKtm8cJtHdMqB5sYDLXrLN6RHxYIa1LhifZu-TPFrlH4uhpbaNwkt3LwRLB1Qz0bAy5eFqHrKWK6pRCs10PRjOCH6zznmCxUlCkEOKJMLycHU8Dv_9dK_3VMXU2hvPKOGo6n43vkbvQr6VEvCPfJDd_ukdt9p8mLPXLnNL6hPyC_v-iVpyu8Z0dkJmq75QXtG4PQXxA591d4dNHSH34DIrJZdcuFpXMQUQ3ubZjqlxCqU4SaCEVW7ZzO0WbipKE6nOINLw1wmW6bmAS_6CLe5_ohOTv--PXDSRr7MaQW_BjsWu9ybgvpa2aywjEPkWzVlFxoXRXCWKlBpX1lDasxW8xIro1kTudV7XVZmfIR2Wm71u8T2mRwKhbMWeMEBKRCaCGtbqQA7437jCckH5ihbAQrx54Z31UIWgRXPQMVMFAFBqrLhLwZ5yx7qI5rqd8jj0dKhNkOH7rVXEWtVQab5EKE1kimmRSZbIRnnnHjmqqptEvIC5QQ1desjsZCHUGQVsEuiDohrwMFmgtYgNWx6gG2AYG3JpQHE0pQczsdHqRQRTOzVlulSMjLcRhnYupc67tzpMlqiMnBM07I415ox0WXdV5k4IEnREzEebIr05F28S2AkGOPZ2CdTMjbQfK3__X_bX9y_TKekt0i6CRLC3lAdjarc_8MvL6NeR5U-w_A-1U9 priority: 102 providerName: ProQuest – databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1baxUxEA5aQXwR726tGkHwQRd3N5dNHuvBUoT6IBb6FnLb44G653DOqdD-An-2M9lLu_UCvm5mIJuZTGaSmW8Iec29dSpGnuvAWM6dl7mODp_YFfMlD6ACWJx89FkeHvNPJ-Kkh8nBWpir7_elku83ZSkxqadiOQQiiuUXN8ktAYYXtXkmZ4PVlQx846Eo5o98k4Mn4fP_boWvHEPXUySvvZOm4-fgHrnb-410vxP0fXIjtg_I7aP-Zfwh-fnFriNd4-054i1Rv1yd067dB_0B8XB3MUcXLf0etyD47Xq5Wng6B8Wz4LQm1riCAJwigEQqnWrndI6WEJmGmm-K97Y0gWCGy3QjmFjoUTw3j8jxwcevs8O877KQe_BOsBd9KKWvdKy5K6rAI8SnomFSWSsq5by2sFGj8I7XmAPmtLRO82BLUUfLhGOPyU67bONTQpsCzrqKB--CgjBTKau0t41W4JPJWMiMlIMIjO8hyLETxqlJoYiSphObAbGZJDZzkZG3I8-qA-D4J_UHlOxIieDZ6QPolOn3onHY-hbirkZzy7UqdKMij1y60IhG2JCRl6gXpqtEHU2A2YfQS8AqqDojbxIFGgH4AW_7WgZYBoTTmlDuTShh8_rp8KB7pjceG1Mhgo9A5y0jr8Zh5MSEuDYuz5CmqCHSBn83I086VR1_mtVlVYBfnRE1UeLJqkxH2sW3BC2OnZtBdDoj7wZ9v5zX35d99__In5E7VdqZPK_0HtnZrs_ic_Dttu5F2tS_AEnGSes priority: 102 providerName: Springer Nature |
Title | Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders |
URI | https://link.springer.com/article/10.1186/s11689-023-09483-z https://www.ncbi.nlm.nih.gov/pubmed/37120522 https://www.proquest.com/docview/2815650078 https://www.proquest.com/docview/2807917551 https://pubmed.ncbi.nlm.nih.gov/PMC10148449 https://doaj.org/article/b1950642f94a49809f8e4e46bdf5f5ad |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gNKXse956zINBnvYvNqyLEsPY6ShpQxaRlkgb0aS5SzQOZmTjrV_wf7s3cl2OnftXgy2TiDrfifdSfdByBtutZHO8VAVSRJyY0WonMErdpnYmBcAAQxOPjkVx2P-eZJONkhX7qidwOWtph3WkxrX5x9-_bj8BAL_0Qu8FPvLOBbo-MOSEIwVmYRXm2Tb3xehKx9f3yqIBPTnLnDm1n67ZCfJYhaljPX2KZ_O_99F-69d66ZH5Y1rVb9bHd0n91o1kw4bXDwgG656SHZO2ov0R-T3ma4drfGwHdMzUTtfXNKmOgj9CeZzc45HZxX97laAk1U9X8wsnQJONei4vqtbgL1OMd-Ej7SqpnSKCyd26kLEKR7zUp8zs7j2ToKBFW3Sz-VjMj46_Do6DtuiDKEFZQZL1xexsEy5jJuIFdyBOZuWiZBap0waqzTItUut4Rm6jBkltFG80HGaOZ2kJnlCtqp55Z4RWkawNTJeWFNIsEql1FJZXSoJKpxwkQhI3LEgt23GciyccZ57y0WKvOFgDhzMPQfzq4C8W_dZNPk6_kt9gJxdU2Kubf9hXk_zVnRzg5VywUwrFddcyUiV0nHHhSnKtEx1EZBXiIu8CVxdrxj5ECy1FGZBZgF56ykQxfADVrehDzANmH2rR7nXowRZt_3mDnt5Jyo5w4Q_Kep6AXm9bsae6D9XufkF0kQZGOagHgfkaQPV9U93iA-I7IG4Nyv9lmr2zWcix0LPwDoVkPcd3q_Hdfe0P79zDC_ILvPyyEOm9sjWqr5wL0HrW5kB2cwm2YBsHxyefjmDt5EYDfwJysALOTzHbPgHjApY4g |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEY8LgvIKFGokEAeImoeT2AeEyqPa0m4PqJX25tqOs6wEyZLdgra_gF_Db2TGSXZJEb31Go-jxDOehz3zDSHPmVGaW8t8kcexz7RJfWE1XrHz2IQsBxHA4uThYTo4Zp9GyWiN_O5qYTCtstOJTlHnlcEz8u0IYU0StGhvp9997BqFt6tdC41GLPbt4ieEbLM3ex-Avy-iaPfj0fuB33YV8A1YY-y9noepiYTNmA6inFmIx5IiTrlSScS1EQoE0yZGswxznrRIlRYsV2GSWRUnOob3XiFXGV4xwv7JRssAL4UXYcokYsj5oWBZV6TD0-1ZGKaYnBTFPgRUPPbPeobQ9Qv41yr8ZRbPp2yeu7d15nD3NrnV-rF0pxG8O2TNlhvkWtPZcrFBrg_bO_u75NdnVVta47k-IkFRU00XtGlEQn9ApN4cGdJJSb_ZOYjkvK6mE0PHsCUUuNNuqp3Oq5oitIUr6irHdIw6Gid11egUT5Spg-fMV4lQ8Il5iy86u0eOL4VT98l6WZX2IaFFAFY4YrnROYcAmHPFhVGF4OAtpjZIPRJ2zJCmBUfHHh1fpQuSeCobBkpgoHQMlGceebWcM22gQS6kfoc8XlIirLd7UNVj2WoJqbEpL0SEhWCKCR6IgltmWarzIikSlXtkCyVENjWyS-UkdyAoTGAVeOaRl44C1RP8gFFtlQUsAwJ99Sg3e5SgVkx_uJNC2aq1mVxtQo88Ww7jTEzVK211ijRBJsApTUKPPGiEdvnTcRZGAXj8HuE9ce6tSn-knHxxoOfYUxpYJzzyupP81Xf9f9kfXfwbW-TG4Gh4IA_2Dvcfk5uR25_Mj8QmWZ_Xp_YJeJxz_dRtc0pOLluv_AGg8pF6 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9QwELagSBUvqJwNLdRISDxA1ByOYz8ux6ocrRBipb5ZvrKsBNlod4tEfwE_mxnnaFMOidd4LDmewzP2zDeEPGVWG-E9i6XL85gZy2PpDT6xi9ymzIEIYHHy8Qk_mrF3p8XppSr-kO3eP0m2NQ2I0lRvDhtXtSou-OE6TTmm-mR5DOGJyOPz6-QGg7Mak7pm2aS3xTwHj7kvlfnjvNFxFFD7f7fNlw6nq4mTV15Pw6E03SG3Om-STlr23ybXfH2HbB937-V3yc9PeuXpCu_UEYWJ2mXzg7ZNQOh3iJLb6zq6qOk3vwFx2KyWzcLSOYijBlc2TPUNhOUUYSVCQVU9p3O0jziprwSneJtLAzSmu0hCgoW5DttzfY_Mpm8-vzqKu94LsQWfBTvUu5TbTPqSmSRzzEPUWlQ5F1oXmTBWalBfX1jDSswMM5JrI5nTaVF6nRcmv0-26mXtdwmtEjgBM-ascQKCTyG0kFZXUoCnxn3CI5L2LFC2AybH_hhfVQhQBFct2xSwTQW2qfOIPB_mNC0sxz-pXyJnB0qE1A4flqu56jRUGWyIC9FYJZlmUiSyEp55xo2riqrQLiIHKBeqrU8dDIOaQEBWwC6IMiLPAgWaBvgBq7sKB9gGBNkaUe6PKEGl7Xi4lz3VmZS1yhDXp0CXLiJPhmGciWlytV-eIU1SQvwNXnBEHrSiOvx0XqZZAt52RMRIiEe7Mh6pF18C4Dj2cwbWyYi86OX9Yl1_3_aH_0d-QLY_vp6qD29P3u-Rm1lQUhZncp9sbVZn_hE4fxvzOOj3L8ZVVUA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rare+recurrent+copy+number+variations+in+metabotropic+glutamate+receptor+interacting+genes+in+children+with+neurodevelopmental+disorders&rft.jtitle=Journal+of+neurodevelopmental+disorders&rft.au=Glessner%2C+Joseph+T&rft.au=Khan%2C+Munir+E&rft.au=Chang%2C+Xiao&rft.au=Liu%2C+Yichuan&rft.date=2023-04-29&rft.eissn=1866-1955&rft.volume=15&rft.issue=1&rft.spage=14&rft_id=info:doi/10.1186%2Fs11689-023-09483-z&rft_id=info%3Apmid%2F37120522&rft.externalDocID=37120522 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1866-1955&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1866-1955&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1866-1955&client=summon |